Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
Doxorubicin is one of the most effective chemotherapeutic agents; however, it has various side effects, such as cardiotoxicity. Therefore, novel methods are needed to reduce its adverse effects. Quercetin is a natural flavonoid with many biological activities. Liposomes are lipid-based carriers wide...
Saved in:
Main Authors: | Hamidreza Dorostkar (Author), Bibi Fatemeh Haghiralsadat (Author), Mahdie Hemati (Author), Fatemeh Safari (Author), Azam Hassanpour (Author), Seyed Morteza Naghib (Author), Mohammad Hossein Roozbahani (Author), M. R. Mozafari (Author), Ali Moradi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats
by: Patricia Lorena Dulf, et al.
Published: (2024) -
Fluorouracil and doxorubicin - cardiotoxic cytostatics in the workplace
by: Małgorzata Kupczewska-Dobecka, et al.
Published: (2020) -
Cardiotoxicity of doxorubicin - causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023) -
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
by: Xiaoxiao Lin, et al.
Published: (2023)